First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis.

Strahlenther Onkol · 2024 · PMC11186867 · PMID 37975883

Europe PMC DOI

hedged sentences

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

a clear trendp = 0.052so close (0.05 < p ≤ 0.1)

Patients initially treated with ICI sowed a clear trend towards longer post-DM-survival of 20.7 (95% CI: 13.9–27.6) vs 7.8 (95% CI: 4.4–11.5) months ( p = 0.052).

also in 4,369 other papers

showed a trendno p-value reported

Patients with higher SUVmax (≥ 13.75) also showed a trend towards shorter median DMFS.

also in 11,799 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.